Israel-based biotech Vascular Biogenics (NASDAQ:VBLT), operating as VBL Therapeutics, added ~85% after the company and U.S. privately-held firm Notable Labs, Inc. announced a merger agreement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback